Home › ImStar Therapeutics Selects Lead Drug Candidate For ALS
 

Keywords :   


ImStar Therapeutics Selects Lead Drug Candidate For ALS

2013-12-04 04:16:22| drugdiscoveryonline News Articles

ImStar Therapeutics today announced the selection of IMS-088 as its lead drug candidate for the treatment of Amyotrophic Lateral Sclerosis (ALS). The company is preparing to initiate IND-enabling studies in the second half of 2014

Tags: als lead drug candidate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Businessman Tony O'Reilly dies after short illness
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »